Corrigendum: Prognostic values and clinical significance of S100 family member’s individualized mRNA expression in pancreatic adenocarcinoma

Corrigendum: Prognostic values and clinical significance of S100 family member’s individualized mRNA expression in pancreatic adenocarcinoma

Show other versions (1)

Bibliographic Details
Main Authors:	Xiaomin Li, Ning Qiu, Qijuan Li
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-10-01
Series:	Frontiers in Genetics
Subjects:	mRNA expression S100 family pancreatic cancer biomarker prognosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2022.1057431/full

Similar Items

Corrigendum: Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma
by: Xiaomin Li, et al.
Published: (2022-01-01)

Prognostic Values and Clinical Significance of S100 Family Member’s Individualized mRNA Expression in Pancreatic Adenocarcinoma
by: Xiaomin Li, et al.
Published: (2021-11-01)

Erratum: Corrigendum: Prognostic values and clinical significance of S100 family member’s individualized mRNA expression in pancreatic adenocarcinoma
by: Frontiers Production Office
Published: (2022-11-01)

Comprehensive analysis of the transcriptional expressions and prognostic value of S100A family in pancreatic ductal adenocarcinoma
by: Hong-Bin Li, et al.
Published: (2021-09-01)

Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy
by: Liao X, et al.
Published: (2018-09-01)

Expressional and Prognostic Value of S100A16 in Pancreatic Cancer Via Integrated Bioinformatics Analyses
by: Gangping Tu, et al.
Published: (2021-04-01)

Relationship between S100A4 protein expression and pre-operative serum CA19.9 levels in pancreatic carcinoma and its prognostic significance
by: Fuxin Jia, et al.
Published: (2019-09-01)

Prognostic values of S100 family members in ovarian cancer patients
by: Yang Bai, et al.
Published: (2018-12-01)

Expression and prognostic impact of FZDs in pancreatic adenocarcinoma
by: Yang Li, et al.
Published: (2021-02-01)

S100A10, a novel biomarker in pancreatic ductal adenocarcinoma
by: Moamen Bydoun, et al.
Published: (2018-11-01)

Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study
by: Eva Peterova, et al.
Published: (2021-01-01)

S100s and HMGB1 Crosstalk in Pancreatic Cancer Tumors
by: Angelo Mandarino, et al.
Published: (2023-07-01)

Comprehensive Analysis of the Prognostic Significance of Hsa-miR-100-5p and Its Related Gene Signature in Stomach Adenocarcinoma
by: Gaoming Wang, et al.
Published: (2021-09-01)

Negative prognostic implications of splenomegaly in nivolumab-treated advanced or recurrent pancreatic adenocarcinoma
by: Shih-Hung Yang, et al.
Published: (2021-01-01)

S100A8, S100A9 and S100A8/A9 heterodimer as novel cachexigenic factors for pancreatic cancer-induced cachexia
by: Wei-Chih Liao, et al.
Published: (2023-06-01)

S100A8 and S100A9 proteins form part of a paracrine feedback loop between pancreatic cancer cells and monocytes
by: Taoufik Nedjadi, et al.
Published: (2018-12-01)

Diagnostic value of S100P, IMP3, Maspin, and pVHL in the differantial diagnosis of pancreatic ductal adenocarcinoma and normal/chronic pancreatitis in fine needle aspiration biopsy
by: Aysegul Aksoy-Altinboga, et al.
Published: (2018-01-01)

Prognostic Biomarkers for Pancreatic Ductal Adenocarcinoma: An Umbrella Review
by: Yizhi Wang, et al.
Published: (2020-09-01)

S100 Proteins in Pancreatic Cancer: Current Knowledge and Future Perspectives
by: Yu Wu, et al.
Published: (2021-08-01)

High expression of LAMA3/AC245041.2 gene pair associated with KRAS mutation and poor survival in pancreatic adenocarcinoma: a comprehensive TCGA analysis
by: Chengming Tian, et al.
Published: (2021-06-01)

Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma
by: Yi Han, et al.
Published: (2023-02-01)

Identification of tumor antigens and immune subtypes of pancreatic adenocarcinoma for mRNA vaccine development
by: Xing Huang, et al.
Published: (2021-03-01)

An immune-related gene prognostic risk index for pancreatic adenocarcinoma
by: Yang Su, et al.
Published: (2022-07-01)

Prognostic Role of S100A8 and S100A9 Protein Expressions in Non-small Cell Carcinoma of the Lung
by: Hyun Min Koh, et al.
Published: (2019-01-01)

Novel prognostic signature for lung adenocarcinoma based on immune-related mRNA pairs
by: Jiawei Yue, et al.
Published: (2024-02-01)

AQP5 Is a Novel Prognostic Biomarker in Pancreatic Adenocarcinoma
by: Guo Chen, et al.
Published: (2022-05-01)

Corrigendum: Serum Biomarker Panel for Diagnosis and Prognosis of Pancreatic Ductal Adenocarcinomas
by: Shreya Mehta, et al.
Published: (2021-10-01)

Discovering ferroptosis-associated tumor antigens and ferroptosis subtypes in pancreatic adenocarcinoma to facilitate mRNA vaccine development
by: Ting Yan, et al.
Published: (2024-03-01)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
by: Dongjie Chen, et al.
Published: (2021-10-01)

S100A10 Promotes Pancreatic Ductal Adenocarcinoma Cells Proliferation, Migration and Adhesion through JNK/LAMB3-LAMC2 Axis
by: Hai Lin, et al.
Published: (2022-12-01)

Anoikis-Related Gene Signature for Prognostication of Pancreatic Adenocarcinoma: A Multi-Omics Exploration and Verification Study
by: Jin Zhang, et al.
Published: (2023-06-01)

Identification of therapeutic targets and prognostic biomarkers among CC chemokines in the pancreatic adenocarcinoma microenvironment
by: Xinyuan Liu, et al.
Published: (2023-04-01)

Comprehensive analysis identifies cuproptosis-related gene DLAT as a potential prognostic and immunological biomarker in pancreatic adenocarcinoma
by: Xiaoling Zhang, et al.
Published: (2023-06-01)

Identification and Validation of Circulating Micrornas as Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma Patients Undergoing Surgical Resection
by: Natalia Gablo, et al.
Published: (2020-07-01)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
by: Xiong Tian, et al.
Published: (2022-07-01)

Prognostic Value of Transfer Learning Based Features in Resectable Pancreatic Ductal Adenocarcinoma
by: Yucheng Zhang, et al.
Published: (2020-10-01)

Plasminogen Activator Inhibitor 1 as a Poor Prognostic Indicator in Resectable Pancreatic Ductal Adenocarcinoma
by: Wen-Jing Liu, et al.
Published: (2018-01-01)

Circulating Protein Biomarkers for Prognostic Use in Patients with Advanced Pancreatic Ductal Adenocarcinoma Undergoing Chemotherapy
by: Sidsel C. Lindgaard, et al.
Published: (2022-07-01)

Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery
by: Maria João Amaral, et al.
Published: (2023-02-01)

Development and validation of a novel 3-gene prognostic model for pancreatic adenocarcinoma based on ferroptosis-related genes
by: Jihua Yang, et al.
Published: (2022-01-01)